Larson Financial Group LLC Intercept Pharmaceuticals, Inc. Transaction History

Larson Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$39.09 - $53.44 $3,518 - $4,809	-90 Closed	0 $0
Q2 2020 Jul 10, 2020	SELL	$46.7 - $92.04 $14,430 - $28,440	-309 Reduced 77.44%	90 $4,000
Q1 2020 Apr 09, 2020	SELL	$48.35 - $118.68 $2,562 - $6,290	-53 Reduced 11.73%	399 $25,000
Q4 2019 Jan 10, 2020	SELL	$57.36 - $124.1 $5,219 - $11,293	-91 Reduced 16.76%	452 $56,000
Q3 2019 Oct 11, 2019	BUY	$58.69 - $80.46 $30,812 - $42,241	525 Added 2916.67%	543 $36,000
Q2 2019 Jul 16, 2019	BUY	$77.77 - $120.68 $1,399 - $2,172	18 New	18 $1,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Larson Financial Group LLC with notifications on news.